These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3301661)

  • 1. Statistical methods in cancer research. Volume III--The design and analysis of long-term animal experiments.
    Gart JJ; Krewski D; Lee PN; Tarone RE; Wahrendorf J
    IARC Sci Publ; 1986; (79):1-219. PubMed ID: 3301661
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of interaction between carcinogens in long-term factorially designed animal experiments.
    Machado SG; Bailey KR
    Biometrics; 1985 Jun; 41(2):539-45. PubMed ID: 4027328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonparametric methods for survival/sacrifice experiments.
    Dewanji A; Kalbfleisch JD
    Biometrics; 1986 Jun; 42(2):325-41. PubMed ID: 3741974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of age-adjusted tests in animal carcinogenicity experiments.
    Ryan LM
    Biometrics; 1985 Jun; 41(2):525-31. PubMed ID: 4027327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical analysis of animal cancer chemoprevention experiments.
    Freedman LS; Midthune DN; Brown CC; Steele V; Kelloff GJ
    Biometrics; 1993 Mar; 49(1):259-68. PubMed ID: 8513108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incorporation of historical control information in tests of proportions: simulation study of Tarone's procedure.
    Tamura RN; Young SS
    Biometrics; 1986 Jun; 42(2):343-9. PubMed ID: 3755626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic requirements for long-term assays for carcinogenicity.
    Feron VJ; Grice HC; Griesemer R; Peto R; Agthe C; Althoff J; Arnold DL; Blumenthal H; Cabral JR; Della Porta G; Ito N; Kimmerle G; Kroes R; Mohr U; Napalkov NP; Odashima S; Page NP; Schramm T; Steinhoff D; Sugar J; Tomatis L; Uehleke H; Vouk V
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):21-83. PubMed ID: 6935180
    [No Abstract]   [Full Text] [Related]  

  • 8. Statistical analysis of animal cancer chemoprevention experiments.
    Marimuthu P
    Biometrics; 1996 Sep; 52(3):1157. PubMed ID: 8805772
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinogenesis studies design and experimental data interpretation/evaluation at the National Toxicology Program.
    Huff JE; Moore JA
    Prog Clin Biol Res; 1984; 141():43-64. PubMed ID: 6718388
    [No Abstract]   [Full Text] [Related]  

  • 10. A Bayesian approach to the multiplicity problem for significance testing with binomial data.
    Meng CY; Dempster AP
    Biometrics; 1987 Jun; 43(2):301-11. PubMed ID: 3607202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating tumor incidence rates in animal carcinogenicity experiments.
    Dinse GE
    Biometrics; 1988 Jun; 44(2):405-15. PubMed ID: 3390506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal designs for the analysis of interactive effects of two carcinogens or other toxicants.
    Wahrendorf J; Zentgraf R; Brown CC
    Biometrics; 1981 Mar; 37(1):45-54. PubMed ID: 7248443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of animal carcinogenicity experiments with multiple tumor types.
    Lu Y; Malani HM
    Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal model for colorectal cancer.
    Nigro ND
    Prog Clin Biol Res; 1985; 186():161-73. PubMed ID: 4034597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of a human tumour xenograft to chemotherapy: intrinsic variation between tumours and its significance in planning experiments.
    Warenius HM; Freedman LS; Bleehen NM
    Br J Cancer Suppl; 1980 Apr; 4():128-32. PubMed ID: 6932916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer research--validity of its methods (2)].
    Sato H
    Nihon Rinsho; 1981 May; 39(5):2230-5. PubMed ID: 7289085
    [No Abstract]   [Full Text] [Related]  

  • 17. Some pharmaceutical drugs.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():1-337. PubMed ID: 6937434
    [No Abstract]   [Full Text] [Related]  

  • 18. Biostatistical approaches to reducing the number of animals used in biomedical research.
    Puopolo M
    Ann Ist Super Sanita; 2004; 40(2):157-63. PubMed ID: 15536265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop.
    Kallman RF; Brown JM; Denekamp J; Hill RP; Kummermehr J
    Cancer Res; 1985 Dec; 45(12 Pt 1):6541-5. PubMed ID: 4063999
    [No Abstract]   [Full Text] [Related]  

  • 20. The statistical analysis of cancer inhibition/promotion experiments.
    Kokoska SM; Hardin JM; Grubbs CJ; Hsu C
    Anticancer Res; 1993; 13(5A):1357-63. PubMed ID: 8239506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.